LogiPep MOTS-C Pre Mixed Pen | 5mg/ 10mg / 20mg

Overview of MOTS-c

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a mitochondria-derived peptide encoded within mitochondrial DNA. It is being studied for its potential involvement in cellular metabolism, stress responses, mitochondrial signalling and age-associated biological changes. Most proposed applications remain experimental and require further clinical investigation.

MOTS-c and Ageing Research

Researchers are investigating whether MOTS-c helps cells adapt to metabolic and mitochondrial stress associated with ageing. Preclinical findings suggest possible links with AMPK signalling, glucose regulation and mitochondrial homeostasis. Its relevance to age-related functional decline and neurodegenerative conditions remains under investigation.

MOTS-c and Metabolic Research

Laboratory and animal studies have examined the relationship between MOTS-c, glucose utilisation, insulin sensitivity, fatty-acid metabolism and inflammatory signalling. These findings have prompted interest in its possible relevance to obesity, type 2 diabetes and metabolic syndrome, although therapeutic effectiveness in humans has not been established.

MOTS-c and Physical Performance

MOTS-c is being studied for its potential influence on skeletal-muscle metabolism, mitochondrial efficiency and adaptation to physical activity. Research has explored possible associations with endurance, recovery and age-related muscle decline, but evidence supporting performance-related use in humans remains limited.

MOTS-c and Obesity Research

Preclinical research suggests MOTS-c may affect energy expenditure, fat metabolism and mitochondrial activity in adipose tissue. Scientists are examining whether these mechanisms could be relevant to visceral fat accumulation, obesity and metabolic conditions such as non-alcoholic fatty liver disease.

MOTS-c and Insulin Resistance

Studies have explored whether MOTS-c influences cellular glucose uptake and insulin signalling through pathways including AMPK. Its possible effects on inflammatory processes associated with metabolic dysfunction are also being investigated. Further human research is required to determine its clinical significance.

MOTS-c and Cardiovascular Research

MOTS-c has been examined for possible roles in endothelial function, cellular stress responses and protection against oxidative damage. These mechanisms may be relevant to cardiovascular conditions associated with metabolic and mitochondrial dysfunction, but current evidence is not sufficient to establish a therapeutic benefit.

MOTS-c in Cancer Research

Researchers are investigating how MOTS-c interacts with cellular energy metabolism and mitochondrial signalling in cancer models. Its relationship with tumour metabolism, including pathways associated with the Warburg effect, remains an early-stage research area. Its effects may vary by cancer type and biological context.

MOTS-c and Neurological Research

MOTS-c is also being studied in relation to neuronal metabolism, oxidative stress and mitochondrial resilience. Early research has considered its possible relevance to neuroplasticity and neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. These potential applications remain investigational and have not been clinically established.